TMC 649128Alternative Names: HCV-POL (TMC649128) - Medivir/Tibotec/J&J; TMC649128
Latest Information Update: 25 Nov 2011
At a glance
- Originator Medivir AB
- Class Antivirals
- Mechanism of Action Hepatitis C virus NS 5 protein inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Hepatitis C